Labshake search
Citations for Biovision :
1 - 17 of 17 citations for Recombinant Cynomolgus FCGR2A His tagged since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Synthetic Biology 2022Quote: ... his-tagged extracellular domain of the growth hormone receptor (GHR, BioVision 7477-10) was immobilized on the Ni-NTA sensor tip by dipping the tips in a 2.5 μg/ml solution of GHR for 400 s ...
-
bioRxiv - Cancer Biology 2023Quote: ... The HIS-tagged protein was purified on Ni-NTA (cat. no. 6562; BioVision; abcam, Inc.) column ...
-
bioRxiv - Cancer Biology 2021Quote: ... Recombinant Human Wnt 3a (BioVision) was administered at 150 ng/ml for 24 hours ...
-
bioRxiv - Molecular Biology 2019Quote: ... and recombinant active caspase 3 (0.5 μg; Chemicon) or recombinant active caspase 7 (0.5 μg; Biovision) were incubated for 3 h in cleavage assay buffer (50 mM Hepes ...
-
bioRxiv - Immunology 2019Quote: ... cultures were supplemented with recombinant SCF (50ng/ml; BioVision), G-CSF (20ng/ml ...
-
bioRxiv - Cell Biology 2019Quote: ... Recombinant human IFN-α2a was purchased from BioVision (Milpitas, CA). In the present experiments Huh7 cultures were exposed for two days to IFN-α at a concentration of 3,000 IU/ml prior in DMEM supplemented with 2% FBS prior to prior to fixation and immunofluorescence analyses (22).
-
bioRxiv - Biochemistry 2022Quote: ... Recombinant human IFN-α2 was purchased from BioVision (Milpitas, CA) and typically used at 10-20 ng/ml for 2 days ...
-
bioRxiv - Cell Biology 2019Quote: ... and 10ng/ml IGF-1 (recombinant human, BioVision, San Francisco, CA). Media was changed on alternate days over a 10-day period.
-
bioRxiv - Biophysics 2021Quote: The PSF was characterised using purified recombinant EGFP (Biovision, Milpitas, California) diluted to a final concentration of 20 mM in PBS (Gibco ...
-
bioRxiv - Immunology 2021Quote: ... 100 µl of rabbit anti-His-tag antibody (1:1000, BioVision, USA, cat#3998) was incubated at 37℃ for 2 h and washed as described above ...
-
bioRxiv - Genetics 2023Quote: ... 1% PS and 5ng/ml human recombinant TGF-β1 (Biovision, 4342-5). This medium was changed every 4 days and after 14 days ...
-
bioRxiv - Synthetic Biology 2022Quote: ... the 10 % PVA inner phase was supplemented with 32.7 kDa recombinant EGFP (Biovision) mixed to a final concentration of 2 µg/mL or 60 kDa FITC-labeled streptavidin (Biolegend ...
-
bioRxiv - Microbiology 2021Quote: ... PBMCs were differentiated into mature macrophages with human recombinant macrophage colony stimulating factor (BioVision) in RPMI 1640 media supplemented with 20% human AB serum (Corning ...
-
bioRxiv - Genetics 2023Quote: ... 1% P/S and 5ng/ml active human recombinant TGF-β1 (Biovision, 4342-5). This medium was replaced every 4 days ...
-
bioRxiv - Immunology 2021Quote: ... 10 μM PS341 and 10 μM PR619 for 15 minutes on ice followed by addition of 5 Units of active recombinant caspase-1 (Biovision). This lysate was incubated at 37 °C for 80 minutes and samples subsequently diluted in ice-cold DISC buffer (containing 2 mM NEM and Roche complete protease-inhibitor cocktail) ...
-
bioRxiv - Microbiology 2020Quote: ... cells growing on coverslips transfected with plasmids or infected with EBOV were incubated in serum-free-(SF)-DMEM for 1 h and treated without or with 10 ng/mL recombinant human OSM (BioVision) for 15 min (analysis of fixed/immunostained cells ...
-
bioRxiv - Immunology 2020Quote: Infections were performed as described above except KSHV.219 virus was pre-incubated for 30 minutes on ice with serum free RPMI only or serum free RPMI containing recombinant human syndecan-1 protein (rhCD138, BioVision, 7879-10) prior to being added to Naïve B lymphocytes ...